EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.
paper
Cited
Public
- Authors
- Sokhadze, Tato M; Cannon, Rex L; Trudeau, David L
- Year
- 2008
- Journal
- Applied psychophysiology and biofeedback
- PMID
- 18214670
- DOI
- 10.1007/s10484-007-9047-5
- PMCID
- PMC2259255
Electroencephalographic (EEG) biofeedback has been employed in substance use disorder (SUD) over the last three decades. The SUD is a complex series of disorders with frequent comorbidities and EEG abnormalities of several types. EEG biofeedback has been employed in conjunction with other therapies and may be useful in enhancing certain outcomes of therapy. Based on published clinical studies and employing efficacy criteria adapted by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neurofeedback and Research, alpha theta training-either alone for alcoholism or in combination with beta training for stimulant and mixed substance abuse and combined with residential treatment programs, is probably efficacious. Considerations of further research design taking these factors into account are discussed and descriptions of contemporary research are given.
No figures extracted from this document.
| Name | Type |
|---|---|
| 270 male addicts local | cohort |
| 87 subjects local | cohort |
| 94 treatment completers local | cohort |
| Abstaining patients local | cohort |
| abstinence | phenotype |
| abstinence length local | phenotype |
| abstinence-prone local | cohort |
| abstinence-prone group local | cohort |
| Abstinent addicted subjects local | cohort |
| Abstinent heroin-addicted subjects local | cohort |
| Abstinent heroin addicts local | cohort |
| abstinent heroin-dependent subjects local | cohort |
| Abstinent heroin users local | cohort |
| Abstinent methamphetamine dependent patients local | cohort |
| Abstinent polysubstance abusers local | cohort |
| Active heroin abusers local | cohort |
| Acute opioid influence local | phenotype |
| acute THC exposure local | phenotype |
| acute withdrawal | phenotype |
| addicted persons local | cohort |
| addiction | phenotype |
| ADHD | phenotype |
| adolescents | cohort |
| adults | cohort |
| adult substance abusers local | cohort |
| affective disorders | phenotype |
| age | phenotype |
| aggression | phenotype |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol dependence | phenotype |
| Alcohol_dependence | phenotype |
| alcohol-dependent males local | cohort |
| Alcohol-dependent males local | cohort |
| alcohol/drug abuse | phenotype |
| Alcoholics Anonymous | drug |
| alcoholism | phenotype |
| alcoholism development local | phenotype |
| alcohol-related problems | phenotype |
| Alcohol Use | phenotype |
| Alcohol Use Disorder | phenotype |
| alienation | phenotype |
| alpha 2 power local | phenotype |
| Alpha absolute power local | phenotype |
| alpha activity | phenotype |
| Alpha amplitude local | phenotype |
| alpha band | phenotype |
| alpha biofeedback local | drug |
| alpha brainwaves local | phenotype |
| Alpha brainwaves local | phenotype |
| alpha EEG training local | drug |
| Alpha hyperfrontality local | phenotype |
| Alpha interhemispheric coherence local | phenotype |
| Alpha mean frequency local | phenotype |
| alpha oscillations | phenotype |
| alpha power | phenotype |
| Alpha relative power local | phenotype |
| alpha synchrony local | phenotype |
| alpha-theta biofeedback local | drug |
| Alpha-theta brain wave neurotherapy local | drug |
| Alpha-theta EEG biofeedback local | drug |
| Alpha-theta feedback training local | phenotype |
| Alpha-theta neurofeedback local | drug |
| Alpha-theta therapy local | drug |
| alpha-theta training local | drug |
| Alpha theta training local | drug |
| Alpha-theta training local | drug |
| Alternative treatment group local | cohort |
| Americans | cohort |
| Amount of heroin taken daily before withdrawal local | phenotype |
| amplitude | phenotype |
| amygdala | anatomy |
| anger | phenotype |
| anterior | anatomy |
| anterior cingulate cortex | anatomy |
| Anterior Cortex local | anatomy |
| Anterior scalp | anatomy |
| antidepressants | drug |
| antisocial personality disorder | phenotype |
| Anti-social personality disorder | phenotype |
| anxiety | phenotype |
| arrests | phenotype |
| attention | phenotype |
| Attentional variables local | phenotype |
| attention deficit hyperactivity disorder | phenotype |
| audio oddball task local | phenotype |
| Autogenic phrases local | phenotype |
| behavioral adverse outcomes local | phenotype |
| behavioral manifestations local | phenotype |
| behavioral performance | phenotype |
| beta activity | phenotype |
| Beta activity local | drug |
| beta band | phenotype |
| beta band increase local | phenotype |
| beta-endorphin | drug |
| beta frequency band local | anatomy |
| Beta frequency band local | anatomy |
| beta power | phenotype |
| Beta relative power local | phenotype |
| beta training local | drug |
| biofeedback local | drug |
| bipolar disorder | phenotype |
| brain | anatomy |
| brain activity | phenotype |
| Brain atrophy | phenotype |
| brainwave biofeedback local | drug |
| Burkett et al. (2003) local | cohort |
| cannabinoids | drug |
| cannabis abuse local | drug |
| cannabis dependence | phenotype |
| cannabis use | phenotype |
| carbamazepine | drug |
| Catecholamine imbalance local | phenotype |
| central | anatomy |
| central alpha local | phenotype |
| Central frontal region local | anatomy |
| central nervous system | anatomy |
| central region | anatomy |
| chemically dependent outpatients local | cohort |
| Chemically dependent outpatients local | cohort |
| childhood conduct disorder | phenotype |
| children and adolescents at risk for SUD local | cohort |
| chronic alcohol abuse local | drug |
| chronic alcoholism | phenotype |
| chronic brain damage local | phenotype |
| Chronic brain damage local | phenotype |
| Chronic cannabis abuse local | phenotype |
| chronic male alcoholics local | cohort |
| chronic marijuana use | phenotype |
| Chronic marijuana users local | cohort |
| chronic methamphetamine abuse local | phenotype |
| chronic methamphetamine users local | cohort |
| Chronic methamphetamine users local | cohort |
| Clinical SUD populations local | cohort |
| CNS activation local | phenotype |
| CNS disinhibition | phenotype |
| CNS dysfunction | phenotype |
| CNS hyperarousal local | phenotype |
| CNS sedation local | drug |
| cocaine | phenotype |
| cocaine abuse local | drug |
| Cocaine abuse local | drug |
| Cocaine and alcohol-dependent patients local | cohort |
| cocaine- and heroin-dependent group local | cohort |
| Cocaine-Dependent Cohort local | cohort |
| cocaine dependent patients local | cohort |
| cocaine-dependent patients local | cohort |
| Cocaine-dependent patients local | cohort |
| Cocaine positive urine screen local | phenotype |
| Cocaine-preferring polysubstance abusers local | cohort |
| cocaine relapse | phenotype |
| cocaine use disorder | phenotype |
| cocaine withdrawal | phenotype |
| cognition | phenotype |
| cognitive adverse outcomes local | phenotype |
| Cognitive-behavioral therapy local | drug |
| cognitively impaired substance abusers local | cohort |
| college students | cohort |
| conduct disorder | phenotype |
| confidence | phenotype |
| Control alcoholic group local | cohort |
| control alcoholics local | cohort |
| Control condition local | drug |
| control group | cohort |
| controlled study of 121 subjects local | cohort |
| controls | cohort |
| control subjects | cohort |
| Control subjects (no history of alcohol or drug dependence) local | cohort |
| conventional treatment resistant alcoholics local | cohort |
| conventional treatment resistant participants local | cohort |
| cortex | anatomy |
| cortical hyperexcitability local | phenotype |
| Cortical hyperexcitability local | phenotype |
| Cortical inhibition function local | phenotype |
| Cortical local functional connectivity local | phenotype |
| Cortical remote functional connectivity local | phenotype |
| cortical under-arousal local | phenotype |
| crack | drug |
| crack cocaine | phenotype |
| crack cocaine addicts local | cohort |
| Crack cocaine-only users local | cohort |
| Crack cocaine use local | phenotype |
| craving | phenotype |
| cue reactivity | phenotype |
| current crack users local | cohort |
| Current heroin addicts local | cohort |
| Current heroin users local | cohort |
| Current illicit drug users local | cohort |
| Daily THC users local | cohort |
| DeBeus 2002 local | cohort |
| decreased power in slow bands local | phenotype |
| Decreased remote functional connections local | phenotype |
| decrease in alpha frequency local | phenotype |
| decrease in high beta power local | phenotype |
| decrease in relative power of beta local | phenotype |
| decrease in relative power of beta (frontal) local | phenotype |
| decrease in relative power of delta local | phenotype |
| Deep relaxation local | phenotype |
| Deficient alpha amplitude local | phenotype |
| Deficit in alpha activity local | phenotype |
| Deficits in inhibitory control local | phenotype |
| delta activity | phenotype |
| delta band | phenotype |
| Delta band local | drug |
| delta band activity local | phenotype |
| Delta relative power local | phenotype |
| Delta/theta power local | phenotype |
| dependent personality disorder | phenotype |
| depression | phenotype |
| depression scores | phenotype |
| depressive symptoms | phenotype |
| Desynchronization local | phenotype |
| diencephalon | anatomy |
| diminution of alpha rhythm local | phenotype |
| Diminution of alpha rhythm local | phenotype |
| Dineβ (Navajo) local | cohort |
| disulfiram | drug |
| diverse populations | cohort |
| dopamine | drug |
| dopamine agonists | drug |
| dopamine receptor mechanisms alteration local | phenotype |
| dorsolateral prefrontal cortex | anatomy |
| DRD1 | gene |
| DRD2 | gene |
| DRD3 | gene |
| DRD4 | gene |
| DRD5 | gene |
| dropout local | phenotype |
| drug-associated neurotoxicity local | phenotype |
| drug dependence | phenotype |
| Drug neurotoxicity local | phenotype |
| Drug resistance | phenotype |
| drugs | drug |
| drug screens local | phenotype |
| drug-seeking behavior | phenotype |
| Dysphoric motivational state local | phenotype |
| Early heroin abstinence local | phenotype |
| Early opiate withdrawal local | phenotype |
| early treatment failure local | phenotype |
| economic insecurity local | phenotype |
| EEG | phenotype |
| EEG abnormality local | phenotype |
| EEG alpha abnormality local | phenotype |
| EEG alterations local | phenotype |
| EEG beta abnormality local | phenotype |
| EEG biofeedback local | drug |
| EEG biofeedback local | phenotype |
| EEG biofeedback therapy local | drug |
| EEG characteristics local | phenotype |
| EEG coherence | phenotype |
| EEG patterns local | phenotype |
| EEG spectral power local | phenotype |
| EEG synchronization local | phenotype |
| Electrophysiological alterations local | phenotype |
| Elevated synchrony within beta frequency band local | phenotype |
| elevated voltage of non-alpha bands local | phenotype |
| EMG biofeedback local | drug |
| Emotion | phenotype |
| emotional impairment | phenotype |
| emotional reactivity | phenotype |
| employment | phenotype |
| endorphin | drug |
| enhanced fast beta power local | phenotype |
| ERP | phenotype |
| ERP abnormalities local | phenotype |
| ERP changes local | phenotype |
| ERP component latency delays local | phenotype |
| euphoria | phenotype |
| euphoric state local | phenotype |
| Euphoric state local | phenotype |
| event-related potential | phenotype |
| excess alpha activity local | phenotype |
| Excess alpha amplitude local | phenotype |
| excess beta activity local | phenotype |
| excessive delta activity local | phenotype |
| excessive theta activity local | phenotype |
| Excess of beta activity local | phenotype |
| Excess of fast beta activity local | phenotype |
| executive function | phenotype |
| executive functioning | phenotype |
| experimental group | cohort |
| Experimental subjects local | cohort |
| externalizing disorders | phenotype |
| eyes-closed alpha feedback local | drug |
| Fahrion 1995 study local | cohort |
| Fahrion 2002 study local | cohort |
| family history of alcoholism | phenotype |
| Fast alpha range frequency shifts local | phenotype |
| fear | phenotype |
| features local | phenotype |
| Firearm-related deaths local | phenotype |
| frontal alpha local | phenotype |
| Frontal alpha activity local | phenotype |
| Frontal CNS hyperarousal local | phenotype |
| frontal cortex | anatomy |
| frontal delta deficit local | phenotype |
| frontal delta reward local | phenotype |
| Frontal executive deficits local | phenotype |
| frontal hyperarousal local | phenotype |
| frontal neurotoxicity local | phenotype |
| frontal slow-beta coherence local | phenotype |
| frontocentral | anatomy |
| GABA receptor genes | gene |
| generalized anxiety disorder | phenotype |
| general population | cohort |
| Graap and Freides (1998) study local | cohort |
| Habit extinction resistance local | phenotype |
| hallucinations | phenotype |
| Hawthorne effects local | drug |
| healthy controls | cohort |
| healthy non-drug-dependent volunteers local | cohort |
| Heavily drinking males local | cohort |
| Heavy alcohol intake local | phenotype |
| heavy drinking | phenotype |
| Heroin abstinence <80 days subjects local | cohort |
| heroin abuse local | drug |
| Heroin abusers (β₯18 months) local | cohort |
| Heroin-dependent patients local | cohort |
| heroin ex-addicts local | cohort |
| Heroin-related overdose local | phenotype |
| heroin users | phenotype |
| Heroin withdrawal local | phenotype |
| high | phenotype |
| Higher EEG synchrony index for beta range local | phenotype |
| hippocampus | anatomy |
| HIV infection | phenotype |
| homeless crack cocaine abusers local | cohort |
| homelessness | phenotype |
| hypnagogic state local | phenotype |
| illegal behaviors | phenotype |
| Illicit drug dependence or abuse local | phenotype |
| illicit drugs | phenotype |
| inadequacy local | phenotype |
| Increased remote functional connections local | phenotype |
| increase in beta activity local | phenotype |
| Increase in beta activity local | phenotype |
| increase in relative power of alpha local | phenotype |
| Independent superiority study local | cohort |
| Individual insight local | phenotype |
| individuals at high risk to develop alcoholism local | cohort |
| individuals with no history of alcohol or drug dependence local | cohort |
| Induction script local | phenotype |
| Inhibitory control deficit local | phenotype |
| Injury death local | phenotype |
| Inpatient drug program subjects local | cohort |
| Inpatient psychiatric population local | cohort |
| inpatient rehabilitative treatment modality local | drug |
| insomnia | phenotype |
| insula | anatomy |
| Interhemispheric coherence of theta activity local | phenotype |
| interhemispheric coherence over frontal cortex local | phenotype |
| intrusive thoughts | phenotype |
| Investigational treatment local | drug |
| Kansas Prison System local | cohort |
| Large amount of low-amplitude delta waves local | phenotype |
| Large amount of low-amplitude theta waves local | phenotype |
| LaVaque et al. (2002) study local | cohort |
| left-temporal alpha local | phenotype |
| left temporal cortex | anatomy |
| length of stay local | phenotype |
| Level 4 classification local | phenotype |
| level of functioning local | phenotype |
| Light alcohol intake local | phenotype |
| light drinkers | phenotype |
| limbic regions | anatomy |
| lithium | drug |
| Longitudinal opioid exposure local | phenotype |
| low-amplitude delta waves local | phenotype |
| low-amplitude theta waves local | phenotype |
| low delta activity local | phenotype |
| lower frontal alpha coherence local | phenotype |
| lower slow-beta coherence local | phenotype |
| low P300 amplitude local | phenotype |
| low-voltage background activity local | phenotype |
| Low-voltage background activity local | phenotype |
| Low-voltage fast EEG patterns local | phenotype |
| Major affective disorder local | phenotype |
| male addicts local | cohort |
| Males ages 16β23 local | cohort |
| males with alcohol dependence local | cohort |
| marijuana | phenotype |
| Matched non-using control groups local | cohort |
| mazindol local | drug |
| mean alpha frequency local | phenotype |
| medial forebrain bundle | anatomy |
| medial prefrontal cortex | anatomy |
| medication | drug |
| Medication use | drug |
| Meditative state local | phenotype |
| mesial frontal dysfunction local | anatomy |
| mesolimbic system | anatomy |
| Methadone | drug |
| Methadone-maintenance heroin addicts local | cohort |
| methamphetamine | drug |
| methamphetamine dependence | phenotype |
| Methamphetamine dependent patients local | cohort |
| Methamphetamine-dependent patients local | cohort |
| mixed substance abuse population local | cohort |
| MMPI-2 local | phenotype |
| MMPI-2 scales local | phenotype |
| Moderately drinking males local | cohort |
| Moderate-to-heavy alcohol consumption local | phenotype |
| Moderate-to-heavy drinkers local | cohort |
| Modified alpha-theta training local | drug |
| mood altering substance local | drug |
| mood disorders | phenotype |
| morphine | drug |
| Motivational impairment local | phenotype |
| Motivation enhancement therapy local | drug |
| Motor vehicle accidents | phenotype |
| Narrowing of behavioral repertoire local | phenotype |
| Negative family history local | phenotype |
| Negative family history of alcoholism local | cohort |
| nervousness | phenotype |
| Neurocognitive deficits | phenotype |
| neurofeedback local | drug |
| Neurofeedback local | drug |
| neurofeedback training group local | cohort |
| Neurofeedback treatment local | drug |
| neurotherapy local | drug |
| Neurotherapy local | drug |
| neurotoxicity | phenotype |
| nimodipine | drug |
| Non-alcohol SUD local | phenotype |
| non-dependent control group local | cohort |
| Non-drug-using control local | cohort |
| Non-drug-using controls local | cohort |
| Non-methamphetamine using group local | cohort |
| Non-stimulant abusing participants local | phenotype |
| non-users | cohort |
| Non-white participants local | phenotype |
| noradrenaline | drug |
| norepinephrine | drug |
| normal controls | cohort |
| normalization of EEG spectral power local | phenotype |
| normalization of ERP components local | phenotype |
| Normalized spectral power local | phenotype |
| normative groups local | cohort |
| No-treatment control group | cohort |
| nucleus accumbens | anatomy |
| O1 electrode local | anatomy |
| obesity | phenotype |
| observational study of 71 subjects local | cohort |
| obsessive compulsive symptoms local | phenotype |
| Obsessive compulsive symptoms local | phenotype |
| Occipital alpha rhythm peak frequency local | phenotype |
| occipital cortex | anatomy |
| olfactory tubercle | anatomy |
| ongoing cocaine use local | phenotype |
| opiate drug dependent patients local | cohort |
| Opiate physical dependency symptoms local | phenotype |
| opiates | drug |
| opioid | drug |
| opioid dependence | phenotype |
| opioid dependent patients local | cohort |
| Opioid-dependent patients local | cohort |
| Opioid-related overdose local | phenotype |
| orbitofrontal cortex | anatomy |
| Other mental disorders local | phenotype |
| outcome measures local | phenotype |
| Outpatient population local | cohort |
| overdose | phenotype |
| P300 amplitude | phenotype |
| P300 component | phenotype |
| P300 latency | phenotype |
| P300 measures | phenotype |
| P3a amplitude | phenotype |
| P3b amplitude | phenotype |
| P3b latency | phenotype |
| Pain relievers local | drug |
| Papageorgiou et al. 2004 cohort local | cohort |
| parietal alpha local | phenotype |
| parietal cortex | anatomy |
| Past month users local | cohort |
| paternal alcoholism | phenotype |
| Pathological aggression and violence local | phenotype |
| patients dually dependent on cocaine and heroin local | cohort |
| Patients in acute heroin withdrawal local | cohort |
| patients with histories of cocaine and alcohol dependence local | cohort |
| patients with histories of cocaine dependence local | cohort |
| patients with histories of heroin dependence local | cohort |
| Patients with SUD local | cohort |
| Peniston and Kulkosky (1989-1991) study local | cohort |
| Peniston protocol local | drug |
| Peniston Protocol local | cohort |
| Peniston Protocol local | drug |
| persistent elevations of alpha absolute power local | phenotype |
| persistent elevations of alpha relative power local | phenotype |
| Personality states local | phenotype |
| personality traits | phenotype |
| persons aged 12 or older local | cohort |
| Persons aged 12 or older local | cohort |
| phenytoin local | drug |
| Physical dependency symptoms local | phenotype |
| Population treated for a specific problem local | cohort |
| positive outcome local | phenotype |
| positive subjective drug effect local | phenotype |
| PostβCombat PTSD local | phenotype |
| posterior | anatomy |
| posterior alpha power local | phenotype |
| posterior EEG recording sites local | anatomy |
| Posterior scalp | anatomy |
| Post-Traumatic Stress Disorder | phenotype |
| Practiced meditators local | cohort |
| prefrontal cortex | anatomy |
| Prefrontal cortex dysfunction local | anatomy |
| probation comparison group local | cohort |
| probation revocations local | phenotype |
| probation treatment group local | cohort |
| Pronounced desynchronization local | phenotype |
| protracted abstinence | phenotype |
| psychiatric disorders | phenotype |
| Psychiatric status local | phenotype |
| psychodynamic issues local | phenotype |
| psychological adjustment | phenotype |
| Psychomotor slowing local | phenotype |
| psychopathology | phenotype |
| psychosis | phenotype |
| psychostimulant addiction local | phenotype |
| Psychostimulant drug abuse local | phenotype |
| psychostimulants | drug |
| Psychotherapy local | phenotype |
| qEEG local | drug |
| qEEG abnormalities local | phenotype |
| qEEG abnormality local | phenotype |
| qEEG alterations local | phenotype |
| qEEG changes local | phenotype |
| qEEG manifestations local | phenotype |
| qEEG patterns local | phenotype |
| re-arrest rates local | phenotype |
| Recent abstinence local | phenotype |
| Recovering addicts local | cohort |
| Recovering Addicts local | cohort |
| reductions of alpha mean frequency local | phenotype |
| regular residence local | phenotype |
| rejection | phenotype |
| relapse | phenotype |
| relapse-prone local | cohort |
| relapse-prone group local | cohort |
| relapse risk | phenotype |
| Relapse vulnerability | phenotype |
| Relapsing patients local | cohort |
| Relative amplitude deficit local | phenotype |
| Relative power (non-alpha bands) local | phenotype |
| Relative power of beta activity local | phenotype |
| Relative power of delta activity local | phenotype |
| Relatives of alcohol-dependent individuals local | phenotype |
| relaxation | phenotype |
| religiousness local | phenotype |
| residential rehabilitation modalities local | drug |
| residential shelter mission local | cohort |
| resting EEG abnormalities local | phenotype |
| reticular formation local | anatomy |
| Reverie local | phenotype |
| reward | phenotype |
| reward deficiency syndrome | phenotype |
| Reward Deprivation Syndrome local | phenotype |
| right temporal cortex | anatomy |
| right-temporal slow-beta coherence local | phenotype |
| Romano-Micha 2003 local | cohort |
| rumination | phenotype |
| Saxby and Peniston 1995 cohort local | cohort |
| Schizoid-avoidant disorder local | phenotype |
| Schneider et al. (1993) local | cohort |
| Scott et al. (2005) study local | cohort |
| ScottβKaiser approach local | drug |
| Scott Kaiser modification local | drug |
| ScottβKaiser modification local | drug |
| ScottβKaiser modification of the Peniston Protocol local | drug |
| ScottβPeniston treatment local | drug |
| Selective attentional focus on drug cues local | phenotype |
| self-actualization local | phenotype |
| septum pediculum local | anatomy |
| serotonin | drug |
| sex | phenotype |
| Sham (placebo) control local | cohort |
| Slow alpha mean frequency local | phenotype |
| slow-beta coherence local | phenotype |
| Slow cortical potential biofeedback local | drug |
| SMR-beta neurofeedback local | drug |
| social adverse outcomes local | phenotype |
| somatosensory cortex | anatomy |
| specific neurophysiological regions local | anatomy |
| Spectral power local | phenotype |
| stimulant | drug |
| stimulant abuse local | drug |
| Stimulant abuse local | drug |
| stimulant dependence | phenotype |
| stimulants | drug |
| stress | phenotype |
| substance abuse | phenotype |
| substance abuse or dependence disorder local | phenotype |
| substance-induced anxiety disorder local | phenotype |
| substance use | phenotype |
| substantia nigra | anatomy |
| Successful quitting | phenotype |
| SUD | phenotype |
| SUD participants local | cohort |
| suggestibility local | phenotype |
| sustained full remission local | phenotype |
| sustained partial remission local | phenotype |
| TBI local | phenotype |
| Temperature biofeedback local | phenotype |
| temperature control biofeedback local | drug |
| Temperature of 94Β°F local | phenotype |
| Temperature training local | drug |
| temporal | anatomy |
| Thalamic nuclei local | anatomy |
| THC | drug |
| THC users local | cohort |
| Therapist local | drug |
| the substance local | drug |
| theta activity | phenotype |
| Theta amplitude local | phenotype |
| theta band | phenotype |
| theta brainwaves local | phenotype |
| theta oscillations | phenotype |
| Topeka VA local | cohort |
| Topeka VA program local | cohort |
| Tourette's syndrome local | phenotype |
| traditional treatment group local | cohort |
| treatment completion | phenotype |
| Treatment duration local | phenotype |
| treatment failure | phenotype |
| Treatment of established efficacy local | drug |
| treatment program local | cohort |
| Treatment progress local | phenotype |
| treatment retention | phenotype |
| Treatment-seeking cocaine abusers local | cohort |
| unipolar depression | phenotype |
| University of Louisville cohort local | cohort |
| VA hospital inpatients local | cohort |
| ventromedial prefrontal cortex | anatomy |
| visual ERP local | phenotype |
| Visualizations local | drug |
| visual oddball task | phenotype |
| Voltage of non-alpha frequency bands local | phenotype |
| Wait-list control local | cohort |
| withdrawal | phenotype |
| Withdrawal state local | phenotype |
| worse prognosis | phenotype |
| Years of heroin use local | phenotype |
| Ξ9-THC | drug |
No uploaded files.
Not in any collection.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| EEG coherence related to fMRI resting state synchrony in long-term abstinent alcoholics. | 2018 | 29159061 |
| Advances in Electrophysiological Research. | 2015 | 26259089 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Analyze the Potential Benefits of Nature-Based Filming for Young People. | Hassan A et al. | β | 2026 | β |
| Analyzing EEG data during opium addiction treatment using a fuzzy logic-based machine learning model. | DehAbadi E et al. | β | 2025 | β |
| A systematic review on the role of EEG and fMRI-Neurofeedback training in the treatment of substance use disorders and behavioral addiction. | Fathi M et al. | β | 2025 | β |
| Cost, research, and education: Providersβ perspectives on making neurofeedback more accessible | Norris WK et al. | β | 2025 | β |
| Effect of Neurofeedback Training and Swimming Exercise on the Electroencephalographic Changes and Craving in Methamphetamine-dependent Patients. | Fadaei A et al. | β | 2025 | β |
| Effects of Electroencephalographic Biofeedback Therapy on Depression Level, Sleep Quality and Cognitive Function in Patients With Non-Demented Vascular Cognitive Impairment. | Wu L et al. | β | 2025 | β |
| How task-relevant vibratory feedback from an active exoskeleton can lead to ergonomic postures. | Gomes W et al. | β | 2025 | β |
| Improved Response Inhibition Through Cognition-Guided EEG Neurofeedback in Men With Methamphetamine Use Disorder. | Gou H et al. | β | 2025 | β |
| Physical Therapy for Addiction. | Xiao LJ et al. | β | 2025 | β |
| Predicting vasovagal reactions to needles from video data using 2D-CNN with GRU and LSTM. | Rudokaite J et al. | β | 2025 | β |
| The impact of ILF neurofeedback on inhibitory control in high-functioning adolescents with autism spectrum disorder: Preliminary evidence of a randomized controlled trial. | Esmaeilzadeh Kanafgourabi SN et al. | β | 2025 | β |
| The Impact of Transcranial Direct Current Stimulation (tDCS) on Craving and Relapse Rates in Opioid-Dependent Patients Undergoing Methadone Maintenance Therapy. | Khoshkbarchi M et al. | β | 2025 | β |
| Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development. | Blum K et al. | β | 2024 | β |
| Brain regulation training improves emotional competences in patients with alcohol use disorder. | Hack RL et al. | β | 2024 | β |
| Integrated use of biofeedback and neurofeedback techniques in treating pathological conditions and improving performance: a narrative review. | Tosti B et al. | β | 2024 | β |
| Neurofeedback and meditation technology in outpatient offender treatment: a feasibility and usability pilot study. | van der Schoot A et al. | β | 2024 | β |
| Assessing attentional task-related electroencephalogram signal variations by using mobile electroencephalogram technology: An experimental study. | Matsuo M et al. | β | 2023 | β |
| Does combined training of biofeedback and neurofeedback affect smoking status, behavior, and longitudinal brain plasticity? | Pandria N et al. | β | 2023 | β |
| Neurophysiological hallmarks of Huntington's disease progression: an EEG and fMRI connectivity study. | Ponomareva NV et al. | β | 2023 | β |
| Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging. | Murnane KS et al. | β | 2023 | β |
| Comparing LORETA Z Score Neurofeedback and Cognitive Rehabilitation Regarding Their Effectiveness in Reducing Craving in Opioid Addicts. | Faridi A et al. | β | 2022 | β |
| EEG Neurofeedback in the Treatment of Adults with Binge-Eating Disorder: a Randomized Controlled Pilot Study. | Blume M et al. | β | 2022 | β |
| Infra-Low Frequency Neurofeedback in the Treatment of Patients With Chronic Eating Disorder and Comorbid Post-Traumatic Stress Disorder. | Winkeler A et al. | β | 2022 | β |
| Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial. | Gabrielsen KB et al. | β | 2022 | β |
| Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study. | Rempala HA et al. | β | 2022 | β |
| Neurological Mechanisms of Diagnosis and Therapy in School Children with ADHD in Poland. | Nermend M et al. | β | 2022 | β |
| Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis". | Braverman ER et al. | β | 2022 | β |
| The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex. | Ceceli AO et al. | β | 2022 | β |
| A genome-wide association study of interhemispheric theta EEG coherence: implications for neural connectivity and alcohol use behavior. | Meyers JL et al. | β | 2021 | β |
| Alpha activity neuromodulation induced by individual alpha-based neurofeedback learning in ecological context: a double-blind randomized study. | Grosselin F et al. | β | 2021 | β |
| A Novel Cognition-Guided Neurofeedback BCI Dataset on Nicotine Addiction. | Bu J et al. | β | 2021 | β |
| A unifying translational framework to advance treatment research for comorbid PTSD and substance use disorders. | Hien DA et al. | β | 2021 | β |
| Neurofeedback for cognitive enhancement and intervention and brain plasticity. | Loriette C et al. | β | 2021 | β |
| Attentional bias and response inhibition in severe obesity with food disinhibition: a study of P300 and N200 event-related potential. | Iceta S et al. | β | 2020 | β |
| Preventing relapse in alcohol disorder with EEG-neurofeedback as a neuromodulation technique: A review and new insights regarding its application. | Dousset C et al. | β | 2020 | β |
| Abnormalities in the EEG power spectrum in bulimia nervosa, binge-eating disorder, and obesity: A systematic review. | Blume M et al. | β | 2019 | β |
| Binomial Logistic Regression and Artificial Neural Network Methods to Classify Opioid-Dependent Subjects and Control Group Using Quantitative EEG Power Measures. | Erguzel TT et al. | β | 2019 | β |
| Effect of an eight-week smartphone-guided HRV-biofeedback intervention on autonomic function and impulsivity in healthy controls. | Schumann A et al. | β | 2019 | β |
| Effect of deactivation of activity patterns related to smoking cue reactivity on nicotine addiction. | Bu J et al. | β | 2019 | β |
| Efficacy of Biofeedback for Medical Conditions: an Evidence Map. | Kondo K et al. | β | 2019 | β |
| Efficacy of Invasive and Non-Invasive Brain Modulation Interventions for Addiction. | Luigjes J et al. | β | 2019 | β |
| EEG coherence related to fMRI resting state synchrony in long-term abstinent alcoholics. | Cardenas VA et al. | β | 2018 | β |
| Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance UseΒ Disorder Treatment. | Houston RJ et al. | β | 2018 | β |
| Neuroimaging Study of Alpha and Beta EEG Biofeedback Effects on Neural Networks. | Shtark MB et al. | β | 2018 | β |
| Resting-state Abnormalities in Heroin-dependent Individuals. | Pandria N et al. | β | 2018 | β |
| Alpha/Theta Neurofeedback Increases Mentalization and Default Mode Network Connectivity in a Non-Clinical Sample. | Imperatori C et al. | β | 2017 | β |
| Coping food craving with neurofeedback. Evaluation of the usefulness of alpha/theta training in a non-clinical sample. | Imperatori C et al. | β | 2017 | β |
| Investigation of brain electrophysiological properties among heroin addicts: Quantitative EEG and event-related potentials. | Motlagh F et al. | β | 2017 | β |
| Sensorimotor rhythm neurofeedback as adjunct therapy for Parkinson's disease. | Philippens IHCHM et al. | β | 2017 | β |
| Short-term Beneficial Effects of 12 Sessions of Neurofeedback on Avoidant Personality Accentuation in the Treatment of Alcohol Use Disorder. | Dalkner N et al. | β | 2017 | β |
| Therapeutic Applications of BCI Technologies. | McFarland DJ et al. | β | 2017 | β |
| A Randomized Controlled Study of Neurofeedback for Chronic PTSD. | van der Kolk BA et al. | β | 2016 | β |
| Cognitive interventions for addiction medicine: Understanding the underlying neurobiological mechanisms. | Zilverstand A et al. | β | 2016 | β |
| Effects of neurofeedback and computer-assisted cognitive rehabilitation on relative brain wave ratios and activities of daily living of stroke patients: a randomized control trial. | Cho HY et al. | β | 2016 | β |
| Individualized real-time fMRI neurofeedback toΒ attenuate craving in nicotine-dependent smokers. | Hartwell KJ et al. | β | 2016 | β |
| Abnormal reward functioning across substance use disorders and major depressive disorder: Considering reward as a transdiagnostic mechanism. | Baskin-Sommers AR et al. | β | 2015 | β |
| Advances in Electrophysiological Research. | Kamarajan C et al. | β | 2015 | β |
| An assessment of an automated EEG biofeedback system for attention deficits in a substance use disorders residential treatment setting. | Keith JR et al. | β | 2015 | β |
| Effects of neurofeedback on adult patients with psychiatric disorders in a naturalistic setting. | Cheon EJ et al. | β | 2015 | β |
| Neurofeedback Training as a New Method in Treatment of Crystal Methamphetamine Dependent Patients: A Preliminary Study. | Rostami R et al. | β | 2015 | β |
| Neuroplasticity in Human Alcoholism: Studies of Extended Abstinence with Potential Treatment Implications. | Fein G et al. | β | 2015 | β |
| The difficulty of staying awake during alpha/theta neurofeedback training. | SchΓΌtze MD et al. | β | 2015 | β |
| The effect of neurofeedback on a brain wave and visual perception in stroke: a randomized control trial. | Cho HY et al. | β | 2015 | β |
| Alpha-theta border EEG abnormalities in preclinical Huntington's disease. | Ponomareva N et al. | β | 2014 | β |
| Biofeedback for psychiatric disorders: a systematic review. | Schoenberg PL et al. | β | 2014 | β |
| Brain-computer interfaces for EEG neurofeedback: peculiarities and solutions. | Huster RJ et al. | β | 2014 | β |
| EEG-neurofeedback and psychodynamic psychotherapy in a case of adolescent anhedonia with substance misuse: mood/theta relations. | Unterrainer HF et al. | β | 2014 | β |
| Neurofeedback training produces normalization in behavioural and electrophysiological measures of high-functioning autism. | Pineda JA et al. | β | 2014 | β |
| Neuromodulation integrating rTMS and neurofeedback for the treatment of autism spectrum disorder: an exploratory study. | Sokhadze EM et al. | β | 2014 | β |
| Outcomes of neurofeedback training in childhood obesity management: a pilot study. | Chirita-Emandi A et al. | β | 2014 | β |
| Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. | Schulte MH et al. | β | 2014 | β |
| Resting alpha activity predicts learning ability in alpha neurofeedback. | Wan F et al. | β | 2014 | β |
| Self-regulation of human brain activity using simultaneous real-time fMRI and EEG neurofeedback. | Zotev V et al. | β | 2014 | β |
| EEG-Neurofeedback in psychodynamic treatment of substance dependence. | Unterrainer HF et al. | β | 2013 | β |
| Neurofeedback training for opiate addiction: improvement of mental health and craving. | Dehghani-Arani F et al. | β | 2013 | β |
| Peripheral visual performance enhancement by neurofeedback training. | Nan W et al. | β | 2013 | β |
| Real-time fMRI in the treatment of nicotine dependence: a conceptual review and pilot studies. | Hartwell KJ et al. | β | 2013 | β |
| Real-time mental arithmetic task recognition from EEG signals. | Wang Q et al. | β | 2013 | β |
| Automated diagnosis of normal and alcoholic EEG signals. | Acharya UR et al. | β | 2012 | β |
| Functional neuroimaging studies in addiction: multisensory drug stimuli and neural cue reactivity. | Yalachkov Y et al. | β | 2012 | β |
| Management of alcohol abuse. | Albanese AP | β | 2012 | β |
| Self-regulation of brain oscillations as a treatment for aberrant brain connections in children with autism. | Pineda JA et al. | β | 2012 | β |
| Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. | Crunelle CL et al. | β | 2012 | β |
| Training the brain: fact and fad in cognitive and behavioral remediation. | Rabipour S et al. | β | 2012 | β |
| Addiction, adolescence, and the integration of control and motivation. | Gladwin TE et al. | β | 2011 | β |
| Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map. | Chen TJ et al. | β | 2011 | β |
| Single subject task-related BOLD signal artifact in a real-time fMRI feedback paradigm. | Zhang X et al. | β | 2011 | β |
| Acute intravenous synaptamine complex variant KB220β’ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. | Miller DK et al. | β | 2010 | β |
| Biofeedback in medicine: who, when, why and how? | Frank DL et al. | β | 2010 | β |
| Effectiveness of neurofeedback training as a treatment for opioid-dependent patients. | Arani FD et al. | β | 2010 | β |
| Introduction. | Walker JE | β | 2010 | β |
| Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction. | Horrell T et al. | β | 2010 | β |
| Application of a standardized assessment methodology within the context of an evidence-based treatment for substance abuse and its associated problems. | Allen DN et al. | β | 2009 | β |
| Self-perception and experiential schemata in the addicted brain. | Cannon R et al. | β | 2008 | β |